Cargando…
Pathway choice between proteasomal and autophagic degradation
Efficient degradation of abnormal or aggregated proteins is crucial to protect the cell against proteotoxic stress. Selective targeting and disposal of such proteins usually occurs in a ubiquitin-dependent manner by proteasomes and macroautophagy/autophagy. Whereas proteasomes are efficient in degra...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965392/ https://www.ncbi.nlm.nih.gov/pubmed/28813181 http://dx.doi.org/10.1080/15548627.2017.1358851 |
_version_ | 1783325349782749184 |
---|---|
author | Lu, Kefeng den Brave, Fabian Jentsch, Stefan |
author_facet | Lu, Kefeng den Brave, Fabian Jentsch, Stefan |
author_sort | Lu, Kefeng |
collection | PubMed |
description | Efficient degradation of abnormal or aggregated proteins is crucial to protect the cell against proteotoxic stress. Selective targeting and disposal of such proteins usually occurs in a ubiquitin-dependent manner by proteasomes and macroautophagy/autophagy. Whereas proteasomes are efficient in degrading abnormal soluble proteins, protein aggregates are typically targeted for degradation by autophagic vesicles. Both processes require ubiquitin-binding receptors, which are targeted to proteasomes via ubiquitin-like domains or to phagophores (the precursors to autophagosomes) via Atg8/LC3 binding motifs, respectively. The use of substrate modification by ubiquitin in both pathways raised the question of how degradative pathway choice is achieved. In contrast to previous models, proposing different types of ubiquitin linkages for substrate targeting, we find that pathway choice is a late event largely determined by the oligomeric state of the receptors. Monomeric proteasome receptors bind soluble substrates more efficiently due to their higher affinity for ubiquitin. Upon substrate aggregation, autophagy receptors with lower ubiquitin binding affinity gain the upper hand due to higher avidity achieved by receptor bundling. Thus, our work suggests that ubiquitination is a shared signal of an adaptive protein quality control system, which targets substrates for the optimal proteolytic pathway. |
format | Online Article Text |
id | pubmed-5965392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-59653922018-05-30 Pathway choice between proteasomal and autophagic degradation Lu, Kefeng den Brave, Fabian Jentsch, Stefan Autophagy Autophagic Punctum Efficient degradation of abnormal or aggregated proteins is crucial to protect the cell against proteotoxic stress. Selective targeting and disposal of such proteins usually occurs in a ubiquitin-dependent manner by proteasomes and macroautophagy/autophagy. Whereas proteasomes are efficient in degrading abnormal soluble proteins, protein aggregates are typically targeted for degradation by autophagic vesicles. Both processes require ubiquitin-binding receptors, which are targeted to proteasomes via ubiquitin-like domains or to phagophores (the precursors to autophagosomes) via Atg8/LC3 binding motifs, respectively. The use of substrate modification by ubiquitin in both pathways raised the question of how degradative pathway choice is achieved. In contrast to previous models, proposing different types of ubiquitin linkages for substrate targeting, we find that pathway choice is a late event largely determined by the oligomeric state of the receptors. Monomeric proteasome receptors bind soluble substrates more efficiently due to their higher affinity for ubiquitin. Upon substrate aggregation, autophagy receptors with lower ubiquitin binding affinity gain the upper hand due to higher avidity achieved by receptor bundling. Thus, our work suggests that ubiquitination is a shared signal of an adaptive protein quality control system, which targets substrates for the optimal proteolytic pathway. Taylor & Francis 2017-08-16 /pmc/articles/PMC5965392/ /pubmed/28813181 http://dx.doi.org/10.1080/15548627.2017.1358851 Text en © 2017 The Author(s). Published with license byTaylor & Francis http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Autophagic Punctum Lu, Kefeng den Brave, Fabian Jentsch, Stefan Pathway choice between proteasomal and autophagic degradation |
title | Pathway choice between proteasomal and autophagic degradation |
title_full | Pathway choice between proteasomal and autophagic degradation |
title_fullStr | Pathway choice between proteasomal and autophagic degradation |
title_full_unstemmed | Pathway choice between proteasomal and autophagic degradation |
title_short | Pathway choice between proteasomal and autophagic degradation |
title_sort | pathway choice between proteasomal and autophagic degradation |
topic | Autophagic Punctum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965392/ https://www.ncbi.nlm.nih.gov/pubmed/28813181 http://dx.doi.org/10.1080/15548627.2017.1358851 |
work_keys_str_mv | AT lukefeng pathwaychoicebetweenproteasomalandautophagicdegradation AT denbravefabian pathwaychoicebetweenproteasomalandautophagicdegradation AT jentschstefan pathwaychoicebetweenproteasomalandautophagicdegradation |